Prevenotics
Latest round
- Seed
Last raised
- Apr 2022
Total raised
- Undisclosed
Investors
- 2
About Prevenotics
, dba Prevenotics, operates as an AI medical diagnostic software development company that develops technologies that increase the accuracy of cancer diagnosis. As of 2022, Jang Su-yeon is the CEO of the company. The company is developing AI-based cancer and preventive disease diagnosis aids so that people can be less concerned about cancer and more actively manage preventive diseases.
Who invested in Prevenotics
2 investors across 2 rounds
See all investors in Prevenotics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Prevenotics
Who invested in Prevenotics?
Prevenotics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prevenotics raised?
Prevenotics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Prevenotics last raise money?
Prevenotics's most recent round on record is a Seed, in Apr 2022.
What does Prevenotics do?
, dba Prevenotics, operates as an AI medical diagnostic software development company that develops technologies that increase the accuracy of cancer diagnosis.
Where is Prevenotics headquartered?
Prevenotics is headquartered in Seoul, South Korea.
Which VCs invest in companies like Prevenotics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back healthcare it companies at Prevenotics's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like Prevenotics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.